Urethra Neoplasm — Trials

Urethra Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

85 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–85 of 85 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01282463	Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma	completed	Phase 2	148	Eli Lilly and CompanyINDUSTRY	2	Sep 9, 2019	clinicaltrials
NCT01611662	Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer	terminated	Phase 2	32	Fox Chase Cancer CenterOTHER	1	Jul 29, 2019	clinicaltrials
NCT01191892	Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer	completed	Phase 2	82	Cardiff UniversityOTHER	1	May 16, 2019	clinicaltrials
NCT01089088

Data updated 22 days agoSource updated Sep 9, 2019source: clinicaltrials